Seth Rudnick, Director at Aralez Pharmaceuticals Inc. (ARLZ), bought 15,000 shares at $2.26 ($34K) on 2017-03-15, disclosed to the SEC on 2017-03-17.
Open-market purchase of $34k ARLZ by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| GTHX | SELL | 2020-12-23 | $1.3M | — | Filing → |
| GTHX | SELL | 2020-12-10 | $777K | — | Filing → |
| GTHX | SELL | 2020-12-03 | $10K | — | Filing → |